| Prev Close | 122.53 |
| Day Low/High | 119.06 / 121.89 |
| 52 Wk Low/High | 61.61 / 128.54 |
Abbott Laboratories (ABT)
119.18
NYSE
| Exchange | NYSE |
| Shares Outstanding | 1771.53B |
| Market Cap | 217.07B |
| P/E Ratio | 60.02 |
| Div & Yield | N.A. (N.A) |
Focus on Rotation and Not the Direction of the Indices
It isn't just valuation that is likely to drive rotational action.
Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'
Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.
Jim Cramer: 'Excuse Selling'
Let's go over five excuses so you know and are armed with them when they are used and make you faint and weak-handed.
Jim Cramer: An Analyst's Dream
All we have to do is take our cue from companies that boosted their forecasts but their stocks did nothing.
We'll Be Checking on These Corporate Earnings Next Week
Next week the June quarter earnings season maelstrom kicks off with 115 companies, including 32 S&P 500 constituents, reporting their latest quarterly results. In recent days we've seen a number of companies up their outlook for the quarter but we'v...
I Wouldn't Buy Pfizer Shares on This Pop
I would wait until the next down day, and there will be one.
Keeping an Eye on Abbott Labs Stock
The current quarter, according to the analyst community, is understandably not shaping up as stellar.
The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance
I have always liked the aggressive management.
Are You a Trader, Investor, or Opportunist?
Don't pigeon hole yourself into a certain pattern of action when you see opportunities.
Want to Know Why I'm Not Selling Moderna?
I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.
CVS Health Reports and Here's How I'd Play It
CVS Health states that the chain has kept its stores open as an 'essential' retailer through this pandemic.
Jim Cramer: Oil Tanked, and We're in Uncharted Waters
Oil isn't really worthless and Amazon isn't the only retailer that will survive, but we are in a mixed up market thanks to Covid-19.
How I See Market Performance Evolving Over Time, Trading Advanced Micro
Will tech continue to trend toward leadership? Who among us can remember when it has not?
Jim Cramer: How to Stay Safe, Until Quick Testing for Covid-19 Is Available
Welcome to the new era. Social distancing is not without risks, but it is as good as it gets.
My New Multi-Group Portfolio Strategy for Trading the Pandemic
How has my book evolved since the Fed and Treasury rode into town? Here's how.
Most of the Strong Stocks Out There Are Beneficiaries of the Coronavirus Crisis
Although there is great fear of the economic issues that lie ahead, there is still a hunger for speculative action in the market.
5 Ways to Invest in Testing, Vaccines and Clinical Trials
These companies have the potential to help in battling the Covid-19 pandemic.
Assessing the Economic Damage Continues as Hope of Reopening the Economy Builds
There will be some long-lasting changes in behavior that will impact the economy in many ways as it recovers.
Institutions Hold Fire, Abbott Labs Strategy, Zscaler Breakout
Despite the dramatic and highly negative decline in economic activity that forced algos to hit the markets from above, enough portfolio managers faded that move to lessen its impact.
Jim Cramer: I Don't Think Covid-19 Is Invincible
When it's beaten you will wish you own stocks, especially the stocks that are right now lethal to your portfolio.
Jim Cramer: How to Navigate Through This Tricky Moment
Tests, masks, contact tracing, anti-virals. Are those too much to ask?
Inflationary Concerns, Banks Report Earnings, Netflix Soars: Market Recon
I did warn publicly back in another epoch that quantitative easing would lead toward increased consumer level inflation.
Jim Cramer: Now We're Seeing a Work in Progress
As testing expands, drug trials proceed and tech greats are providing a tracking app, I think we're inching toward going back to work -- and further away from going so low again.
I See a Way Into Abbott Labs
ABT is trading lower so far this Monday, and a pull back this week could allow traders a chance to buy weakness.
Decisions at the Local Level Hold the Key to Economic Recovery
Most of the media continues to focus on the national response to the coronavirus.
SAP Could Struggle to Overcome Overhead Chart Resistance
Alhough a key chart shows a new high is possible, the stock of this enterprise software giant could be disappointng for a while.
Good-Bye to March 2020, Retailmageddon, 32% Unemployment? Trading DocuSign
I don't think it would be too much of a stretch to imagine that too many investors, or citizens for that matter, will mind seeing March 2020 head on out of here.
Jim Cramer: Abbott's 5-Minute Covid-19 Test Is a Big Win, but the War Wages On
Now we need the gowns and masks from China to help fight this battle on the front lines.
In a Post-Coronavirus World, Put This Lesser-Known Stock on Your List
Things will be different after Covid-19 and one change will be in how people care about themselves.
